Characteristics of MSM within partnerships and their Neisseria gonorrhoeae isolates
| Number of MSM (number of couples) | 68 (34) |
| Median age (range) | 27 (17–55)* |
| HIV-positive (%) | 5 (7.6%) |
| Median number of male partners in the last 3 months (IQR) | 3 (1–5) |
| Condom use during anal sex in the last 3 months: number of MSM (%) | |
| Always | 9 (14%) |
| Sometimes | 40 (61%) |
| Never | 14 (21%) |
| No anal sex | 3 (5%) |
| Declined to answer | 2 (3%) |
| Sex overseas in the last 12 months: number of MSM (%) | |
| Yes | 12 (18%)† |
| No | 54 (82%) |
| Declined to answer | 2 (3%) |
| Number of culture-positive samples | 94 |
| Median number per partner (IQR) | 1 (1–2) |
| Median number per couple (IQR) | 3 (2–3) |
| Sites with positive culture | |
| Urethral | 32 |
| Pharyngeal | 26 |
| Rectal | 36 |
| Urethral gonorrhoea within partnerships (n=34) | |
| Either man was positive | 30 |
| Both men were positive | 1 |
| Pharyngeal gonorrhoea within partnerships (n=34) | |
| Either man was positive | 19 |
| Both men were positive | 4 |
| Rectal gonorrhoea within partnerships (n=34) | |
| Either man was positive | 24 |
| Both men were positive | 5 |
| Number of different molecular types | |
| NG-MAST | 28 |
| por alleles | 25 |
| tbpB alleles | 18 |
| MLST | 20 |
| Antimicrobial resistance: number of isolates (MIC range, mg/L) | |
| Penicillin DS/resistant | 92 (0.06–2.0) |
| PPNG | 8 |
| Ceftriaxone DS | 6 (<0.008–0.06) |
| Azithromycin-resistant | 0 (≤0.06–0.25) |
| Ciprofloxacin-resistant | 41 (≤0.03–16) |
| Spectinomycin-resistant | 0 (≤64) |
*One patient’s age/date of birth was not available.
†2 New Zealand; 3 England; 2 Italy; 1 Thailand; 2 China; 1 USA; 1 unknown.
DS, decreased susceptibility; MIC, minimum inhibitory concentration; MLST, multilocus sequence typing; MSM, men who have sex with men; NG-MAST, N. gonorrhoeae multiantigen sequence typing; PPNG, penicillinase-producing N. gonorrhoeae.